ROPINIROLE TARBIS 2 mg FILM-COATED TABLETS

2. Before taking Ropinirol Tarbis 2 mg

Do not take Ropinirol Tarbis:

• If you are allergic (hypersensitive) to ropinirol or any of the other ingredients.
• If you have severe liver or kidney disease.
• If you are pregnant, planning to become pregnant, or think you may be pregnant.
• If you are breast-feeding.

Be cautious when taking Ropinirol Tarbis:

• If you have a severe mental disorder.
• If you have a severe heart or vascular disease. You should have your blood pressure checked regularly, especially at the start of treatment.

During treatment with ropinirol, you should be cautious when driving or using machinery. If you experience excessive sleepiness or suddenly fall asleep without feeling sleepy, do not drive or use machinery, and contact your doctor.

Tell your doctor if you notice symptoms such as depression, apathy, anxiety, fatigue, sweating, or pain when stopping or reducing treatment with ropinirol (called dopamine agonist withdrawal syndrome or DAWS). If the symptoms persist after a few weeks, your doctor may need to adjust your treatment.

Using other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription. Some medicines may cause problems if taken with this one.

Be cautious with the following medicines

• Hormone replacement therapy (also called HRT) such as estrogens.
• Ciprofloxacin or enoxacin (antibiotics).
• Fluvoxamine (a medicine used to treat depression).
• Theophylline (a medicine used to treat asthma).

Antipsychotics and other drugs that block dopamine in the brain (such as sulpiride or metoclopramide).

Taking Ropinirol Tarbis with food and drinks

Taking Ropinirol Tarbis tablets with food may reduce the likelihood of you feeling dizzy or nauseous.

Do not drink alcohol while taking this medicine.

Pregnancy and breast-feeding

Consult your doctor or pharmacist before taking any medicine.

Ropinirol should not be taken during pregnancy. Tell your doctor immediately if you are pregnant, think you may be pregnant, or plan to become pregnant. Your doctor will advise you to stop taking this medicine.

Ropinirol should not be used during breast-feeding, as it may affect milk production. Tell your doctor immediately if you are breast-feeding or plan to breast-feed.

Your doctor will advise you to stop treatment with this medicine.

Driving and using machines

Ropinirol may cause excessive sleepiness (somnolence) and sudden sleep episodes.

If you experience these effects, you should avoid driving or using machines, and contact your doctor.

Important information about some of the ingredients of Ropinirol Tarbis:

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

3. How to take Ropinirol Tarbis 2 mg

Follow the instructions for administration of Ropinirol Tarbis exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

Your doctor will decide the dose you need to take each day, and you should follow the instructions given by your doctor.

In case this dose is not feasible, other doses of this product are available.

When you first start taking ropinirol, the dose you take will be gradually increased.

The initial dose is normally 0.25 mg of ropinirol three times a day for the first week.

Then the dose may be increased in increments of 0.25 mg of ropinirol per week, following this scheme:

• Week 1: 0.25 mg three times a day.
• Week 2: 0.5 mg three times a day.
• Week 3: 0.75 mg three times a day.
• Week 4: 1 mg three times a day.

After this first month of treatment, your doctor may gradually increase or decrease the amount of ropinirol you are taking to achieve the best effect.

The dose may be increased at intervals of 0.5 mg of ropinirol per week up to 9 mg per day, following this scheme:

• Week 1: 1.5 mg three times a day.
• Week 2: 2.0 mg three times a day.
• Week 3: 2.5 mg three times a day.
• Week 4: 3 mg three times a day.

Normally, the most effective doseis between 3 and 9 mg per day. In some cases, your doctor may need to increase your daily dose up to a maximum doseof 24 mg per day (8 mg three times a day).

Swallow the tablets whole with a glass of water. Taking the tablets with food may reduce the appearance of nausea (feeling dizzy), which is a possible side effect of this medicine. Do not chew or break the tablets.

You should continue taking your medicine even if you do not feel better, as it may take several weeks for the medicine to take effect. If you think the effect of ropinirol is too strong or too weak, tell your doctor or pharmacist.

Do not take more tablets than your doctor has recommended.

To stop therapy, it is necessary to gradually withdraw ropinirol, reducing the daily doses over a week.

If you take more Ropinirol Tarbis than you should

If you or a child take too many tablets, consult your doctor immediately or go to the hospital and show them the pack of tablets.

The most likely signs of overdose are: feeling dizzy or nauseous, fainting, feeling sleepy and tired, stomach pain, fainting or nervousness.

If you forget to take Ropinirol Tarbis

If you miss a dose of Ropinirol Tarbis, simply continue with the next dose, but do not take a double dose to make up for the missed dose.

If you have any doubts, consult your doctor or pharmacist.

If you stop taking Ropinirol Tarbis

Do not stop taking Ropinirol Tarbis without consulting your doctor or pharmacist.

This is because you should gradually stop taking the medicine, as sudden interruption may worsen your symptoms.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, Ropinirol Tarbis can cause side effects, although not everybody gets them.

The following side effects are very common(affect at least 1 in 10 people):

• Somnolence.
• Fainting (syncope).
• Abnormal involuntary movements (dyskinesia).
• Feeling dizzy (nausea).

The following side effects are common(affect more than 1 in 100 people and less than 1 in 10 people):

• Hallucinations (seeing or hearing things that do not exist) and confusion.
• Fainting (including dizziness).
• Abdominal pain, vomiting, heartburn.
• Swelling of the legs due to water retention (edema).

The following side effects are uncommon(affect more than 1 in 1,000 people and less than 1 in 100 people):

• Psychotic reactions, illusions, paranoia.
• Pathological addiction to gambling.
• Increased sexual desire (libido).
• Extreme daytime sleepiness, sudden sleep episodes without feeling tired beforehand.
• Decreased blood pressure (hypotension) that may make you feel dizzy or faint, especially when standing up from a sitting or lying position. This side effect can be serious in some cases.

The following side effects are rare(affect less than 1 in 10,000 people):

• Increased liver enzymes.

If you think any of the side effects you are experiencing are serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist.

5. Storage of Ropinirol Tarbis 2 mg

Keep out of the reach and sight of children.

Do not use Ropinirol Tarbisafter the expiry date which is stated on the pack after EXP. The expiry date is the last day of the month stated.

Do not store above 25°C.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. FURTHER INFORMATION

Composition of Ropinirol Tarbis

The active substance is ropinirol.

Ropinirol Tarbis 2 mg: Each film-coated tablet contains 2 mg of ropinirol (as hydrochloride).

The other ingredients are:

Core of the tablet: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, magnesium stearate.

Coating of the tablet:

Hypromellose, titanium dioxide (E-171), macrogol 400, yellow iron oxide (E-172), red iron oxide (E-172).

Appearance of Ropinirol Tarbis and pack contents

Film-coated tablet

Ropinirol Tarbis 2 mg: Film-coated tablets, round, pink.

PEAD bottle of 84 tablets.

Marketing authorisation holder

Tarbis Farma, S.L.

Gran Vía Carlos III, 94

08028 Barcelona (Spain)

Manufacturer

• Uriach & Cía, S.A.

Av. Camí Reial 51-57

08184 Palau-solità i Plegamans (Barcelona-Spain)

This leaflet was approved in October 2020